践行可持续发展 以岭药业荣膺“杰出ESG价值传播奖”

Core Insights - Yiling Pharmaceutical (002603) has been awarded the "Outstanding ESG Value Communication Award" for its exceptional practices in Environmental, Social, and Governance (ESG) areas and effective value communication [1][5] - The company’s Secretary of the Board, Wu Rui, and the team have also received the "Outstanding Secretary" and "Outstanding IR Team" awards respectively [1] Group 1: ESG Practices - Yiling Pharmaceutical integrates ESG principles deeply into its corporate strategy and daily operations, recognizing the importance of effectively communicating ESG value to enhance transparency and attract long-term investors [6] - The company actively fulfills its environmental responsibilities by promoting green manufacturing and reducing energy consumption and emissions [6] - Yiling Pharmaceutical adheres to social responsibilities, contributing to traditional Chinese medicine modernization, rural revitalization, and public welfare initiatives [6] Group 2: Corporate Governance and Value Communication - The company continuously improves its governance structure to protect shareholder rights and pursue high-quality development [6] - Yiling Pharmaceutical practices sustainable development by incorporating environmental, social, and governance factors into its corporate strategy and operations, utilizing multiple channels to communicate its ESG values and achievements to the market [6] - The exemplary practices in investor relations management and ESG value communication by Yiling Pharmaceutical provide valuable experience for listed companies and positively contribute to the healthy development of the capital market [6] Group 3: Awards and Recognition - The Panoramic Investor Relations Gold Award has become one of the most influential awards for investor relations management in China, with evaluations conducted by professionals from regulatory bodies and experienced individuals from listed companies [5][6]